XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Number of shares of common stock
Common stock and additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2023   535.4      
Beginning balance at Dec. 31, 2023 $ 6,232   $ 33,070 $ (26,549) $ (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,463     3,463  
Other comprehensive income (loss), net of taxes (47)       (47)
Dividends declared on common stock (2,444)     (2,444)  
Issuance of common stock in connection with equity award programs (in shares)   2.1      
Issuance of common stock in connection with equity award programs 166   166    
Stock-based compensation expense 396   396    
Tax impact related to employee stock-based compensation expense (239)   (239)    
Ending balance (in shares) at Sep. 30, 2024   537.5      
Ending balance at Sep. 30, 2024 7,527   33,393 (25,530) (336)
Beginning balance (in shares) at Jun. 30, 2024   537.2      
Beginning balance at Jun. 30, 2024 5,925   33,204 (27,124) (155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 2,830     2,830  
Other comprehensive income (loss), net of taxes (181)       (181)
Dividends declared on common stock (1,236)     (1,236)  
Issuance of common stock in connection with equity award programs (in shares)   0.3      
Issuance of common stock in connection with equity award programs 67   67    
Stock-based compensation expense 136   136    
Tax impact related to employee stock-based compensation expense (14)   (14)    
Ending balance (in shares) at Sep. 30, 2024   537.5      
Ending balance at Sep. 30, 2024 $ 7,527   33,393 (25,530) (336)
Beginning balance (in shares) at Dec. 31, 2024 536.9 536.9      
Beginning balance at Dec. 31, 2024 $ 5,877   33,533 (27,590) (66)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 6,378     6,378  
Other comprehensive income (loss), net of taxes (356)       (356)
Dividends declared on common stock (2,588)     (2,588)  
Issuance of common stock in connection with equity award programs (in shares)   1.6      
Issuance of common stock in connection with equity award programs 124   124    
Stock-based compensation expense 369   369    
Tax impact related to employee stock-based compensation expense $ (185)   (185)    
Ending balance (in shares) at Sep. 30, 2025 538.5 538.5      
Ending balance at Sep. 30, 2025 $ 9,619   33,841 (23,800) (422)
Beginning balance (in shares) at Jun. 30, 2025   538.3      
Beginning balance at Jun. 30, 2025 7,428   33,680 (25,708) (544)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,216     3,216  
Other comprehensive income (loss), net of taxes 122       122
Dividends declared on common stock (1,308)     (1,308)  
Issuance of common stock in connection with equity award programs (in shares)   0.2      
Issuance of common stock in connection with equity award programs 46   46    
Stock-based compensation expense 127   127    
Tax impact related to employee stock-based compensation expense $ (12)   (12)    
Ending balance (in shares) at Sep. 30, 2025 538.5 538.5      
Ending balance at Sep. 30, 2025 $ 9,619   $ 33,841 $ (23,800) $ (422)